<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Enhancing Phenotype Discovery in Electronic Health Records through Prior Knowledge-Guided Unsupervised Learning - Health AI Hub</title>
    <meta name="description" content="This paper introduces a Bayesian latent class framework that integrates clinical domain knowledge via informative priors to enhance phenotype discovery from ele">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Enhancing Phenotype Discovery in Electronic Health Records through Prior Knowledge-Guided Unsupervised Learning</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.02102v1" target="_blank">2511.02102v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-03
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Melanie Mayer, Kimberly Lactaoen, Gary E. Weissman, Blanca E. Himes, Rebecca A. Hubbard
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> stat.AP, stat.ML
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.02102v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.02102v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a Bayesian latent class framework that integrates clinical domain knowledge via informative priors to enhance phenotype discovery from electronic health record (EHR) data. Applied to a large asthma cohort, it successfully identified an "uncontrolled T2-high" sub-phenotype (38.7% of patients) characterized by elevated eosinophils, allergy markers, and surprisingly high healthcare utilization/medication use. This demonstrates the model's utility for hypothesis generation and cohort identification in heterogeneous diseases lacking clear phenotype definitions.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This methodology is crucial for advancing precision medicine by enabling the discovery of clinically meaningful sub-phenotypes within complex and heterogeneous diseases like asthma. Identifying such subgroups allows for more targeted therapies, personalized patient management strategies, and improved allocation of healthcare resources, ultimately leading to better patient outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper applies Bayesian latent class modeling, an unsupervised machine learning technique, to Electronic Health Records (EHR) data. This AI application is used to discover and characterize clinically meaningful disease sub-phenotypes (e.g., 'uncontrolled T2-high' asthma) by incorporating prior medical knowledge. This facilitates hypothesis generation, patient cohort identification, and potentially leads to more targeted and effective treatment strategies for heterogeneous diseases, thus advancing precision medicine through AI-driven insights from real-world health data.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the limitation of traditional unsupervised learning in EHRs by incorporating domain-specific clinical knowledge (via informative priors) to improve phenotype interpretability and clinical meaningfulness.</li>
                    
                    <li>Utilizes a Bayesian latent class model, capable of modeling missing data (including missing-not-at-random patterns) and providing patient-level phenotype assignment probabilities with uncertainty.</li>
                    
                    <li>Applied the model to a large cohort of 44,642 adult asthma patients from January 2017 to February 2024, specifying informative priors for Type 2 (T2) inflammation-related features.</li>
                    
                    <li>Revealed clear class separation with a bimodal posterior distribution of phenotype assignment, indicating distinct patient subgroups.</li>
                    
                    <li>Identified a significant sub-phenotype (38.7% of the cohort) strongly characterized by elevated eosinophil levels and allergy markers (indicative of T2 inflammation).</li>
                    
                    <li>Notably, this T2-informed class also exhibited high healthcare utilization and medication use, which emerged robustly despite only weakly informative priors on these latter variables.</li>
                    
                    <li>The findings suggest an "uncontrolled T2-high" asthma sub-phenotype, demonstrating the framework's power for hypothesis generation and cohort identification in heterogeneous diseases.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs a Bayesian latent class model, a statistical framework for unsupervised clustering. It integrates clinical domain knowledge by using *informative priors* for specific features (e.g., T2 inflammation-related biomarkers like eosinophils and allergy markers) and *weakly informative priors* for other clinical variables (e.g., healthcare utilization, medication use). The model is designed to handle missing data, accounting for potential missing-not-at-random patterns, and provides patient-level probabilities for phenotype assignment along with associated uncertainty estimates. The approach was applied using reusable and flexible code to a large EHR cohort of asthma patients.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The analysis of 44,642 adult asthma patients revealed a bimodal posterior distribution of phenotype assignment, indicating clear separation into distinct patient classes. A prominent class, comprising 38.7% of the cohort, was characterized by elevated eosinophil levels and allergy markers, consistent with Type 2 inflammation. Crucially, this T2-informed class also demonstrated significantly higher healthcare utilization and medication use, leading to the identification of an 'uncontrolled T2-high' asthma sub-phenotype. This association of T2 inflammation markers with high resource utilization emerged robustly, even with only weakly informative priors on the utilization variables.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This framework offers a powerful tool for clinicians and researchers to move beyond 'one-size-fits-all' approaches for complex diseases. By clearly delineating an 'uncontrolled T2-high' asthma sub-phenotype, it provides actionable insights for personalized treatment decisions, potentially guiding the use of targeted biologics, improving disease management strategies, and optimizing resource allocation for specific patient groups. It facilitates precision medicine by supporting the generation of new clinical hypotheses and the precise identification of patient cohorts for interventional studies.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations. However, potential limitations in such studies typically include dependence on EHR data quality, generalizability of findings to other populations or healthcare systems, and the observational nature of EHR data which inherently limits causal inferences. The work is presented as an illustration of utility, suggesting further validation and broader application would be necessary.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly detailed, the conclusion that the approach 'supports hypothesis generation and cohort identification' implies future directions such as: (1) external validation of the 'uncontrolled T2-high' phenotype in different asthma cohorts, (2) investigation of specific clinical outcomes and differential treatment responses within this identified sub-phenotype, and (3) application of this prior knowledge-guided Bayesian latent class modeling framework to discover novel, clinically relevant sub-phenotypes in other heterogeneous diseases (e.g., COPD, diabetes, autoimmune disorders).</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pulmonology</span>
                    
                    <span class="tag">Allergy & Immunology</span>
                    
                    <span class="tag">Health Informatics</span>
                    
                    <span class="tag">Epidemiology</span>
                    
                    <span class="tag">Internal Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Bayesian latent class model</span>
                    
                    <span class="tag tag-keyword">electronic health records (EHR)</span>
                    
                    <span class="tag tag-keyword">phenotype discovery</span>
                    
                    <span class="tag tag-keyword">asthma sub-phenotype</span>
                    
                    <span class="tag tag-keyword">Type 2 inflammation</span>
                    
                    <span class="tag tag-keyword">precision medicine</span>
                    
                    <span class="tag tag-keyword">unsupervised learning</span>
                    
                    <span class="tag tag-keyword">informative priors</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Objectives: Unsupervised learning with electronic health record (EHR) data
has shown promise for phenotype discovery, but approaches typically disregard
existing clinical information, limiting interpretability. We operationalize a
Bayesian latent class framework for phenotyping that incorporates
domain-specific knowledge to improve clinical meaningfulness of EHR-derived
phenotypes and illustrate its utility by identifying an asthma sub-phenotype
informed by features of Type 2 (T2) inflammation.
  Materials and methods: We illustrate a framework for incorporating clinical
knowledge into a Bayesian latent class model via informative priors to guide
unsupervised clustering toward clinically relevant subgroups. This approach
models missingness, accounting for potential missing-not-at-random patterns,
and provides patient-level probabilities for phenotype assignment with
uncertainty. Using reusable and flexible code, we applied the model to a large
asthma EHR cohort, specifying informative priors for T2 inflammation-related
features and weakly informative priors for other clinical variables, allowing
the data to inform posterior distributions.
  Results and Conclusion: Using encounter data from January 2017 to February
2024 for 44,642 adult asthma patients, we found a bimodal posterior
distribution of phenotype assignment, indicating clear class separation. The T2
inflammation-informed class (38.7%) was characterized by elevated eosinophil
levels and allergy markers, plus high healthcare utilization and medication
use, despite weakly informative priors on the latter variables. These patterns
suggest an "uncontrolled T2-high" sub-phenotype. This demonstrates how our
Bayesian latent class modeling approach supports hypothesis generation and
cohort identification in EHR-based studies of heterogeneous diseases without
well-established phenotype definitions.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Submitted to JAMIA; preprint is the author's original version. Github
  repo: https://github.com/mm4963/prior-guided-EHR-phenotyping/tree/main</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>